SITE Centers Corp. SITC
0.68 USD +0.01 (+1.00%)
At closeNov 10, 2026, 7:17 PM EST
0.70 +0.02 +2.41%
After hours · Nov 10, 7:17 PM ET
0.6614 Day range 0.71545
0.59 52-week range 7.49
- YTD
- -89.41%
- 1 year
- -90.61%
News
globenewswire.com Werewolf Therapeutics' Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting WALTHAM, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), a biopharmaceutical company that has developed conditionally activated…
globenewswire.com GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting GT Biopharma showcased new preclinical data in an oral presentation at SITC demonstrating an enhanced effect of combining GTB-5550, a B7-H3-targeted tri-specific NK cell engager (TriKE®), with a KRAS…
gurufocus.com Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer Johnson and Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancerPR NewswireNEW BRUNSW
globenewswire.com Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data from a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026 SEATTLE, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company…
globenewswire.com MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026) NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies,…
newsfilecorp.com Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer) INTASYL siRNA - Redefining the Treatment Paradigm for Cutaneous Squamous Cell Carcinoma King of Prussia, Pennsylvania--(Newsfile Corp. - November 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO)…
businesswire.com Obsidian Therapeutics to Present Updated Amsoki-cel Efficacy and Pooled Safety Data in Advanced Melanoma at SITC 2026 Annual Meeting CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc. (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered…
globenewswire.com BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026 PHILADELPHIA and VANCOUVER, British Columbia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage…
globenewswire.com Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio Three posters, including a late-breaking presentation, provide new clinical and biomarker data for aglatimagene besadenovec (aglatimagene) in localized prostate cancer and non-small cell lung cancer…
globenewswire.com IMUNON Presents New Translational Data at SITC 2026 Demonstrating How IMNN-001 Activates and Sustains Anti-Tumor T-Cell Immunity in Advanced Ovarian Cancer Analysis of paired patient biopsies from the randomized Phase 2 OVATION 2 study shows IMNN-001 increased CD8+/Treg, CD8+/CD4+ and CD8+/IDO+ ratios in both tumor and stroma
globenewswire.com Atebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026 - Durable complete regressions observed in 50% of mice in a RAS-mutant colorectal cancer model treated with Atebimetinib plus anti-PD-1, with no regrowth even after dosing stopped - - Median survival…
benzinga.com Why Cloudflare Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket Cloudflare jumped 14.6% after beating Q3 estimates; JFrog and Eton gained, while Site Centers and Biostem plunged premarket.
globenewswire.com BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026 Four presentations highlight BriaCell's Bria-OTS+™ cellular immunotherapy platform and BriaPro's CD80-based immunotherapy programs In vitro Bria-OTS+ studies demonstrate immune-cell activation and…
globenewswire.com MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy Webcast to highlight advancement of the randomized Phase 2 trial of agenT-797 in acute lung injury, the ARPA-H collaboration to advance deployable cell therapeutics, and new data released at the…
benzinga.com SITE Centers Q3 FFO $(0.06) Beats $(0.09) Estimate, Sales $4.597M Miss $5.700M Estimate SITE Centers (NYSE:SITC) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 154.55 percent decrease over earnings of $0.11…
businesswire.com SITE Centers Reports Third Quarter 2026 Results BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Reports Third Quarter 2026 Results.
globenewswire.com Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting WALTHAM, Mass., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of…
globenewswire.com Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at the SITC 2026 Annual Meeting Keynote/plenary session and late-breaking poster presentation highlight additional data from Phase 2 AMPLIFY-7P trial of camupepimut (ELI-002 7P) in KRAS-mutated pancreatic cancer Additional…
globenewswire.com Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene Besadenovec Data in Localized Prostate Cancer NEEDHAM, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal…
globenewswire.com GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting SAN FRANCISCO, CALIFORNIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics…
benzinga.com SITE Centers Sells Stake In 10-Property Shopping Center Portfolio Valued At $644M To Pine Tree Pine Tree, a national owner and operator of open-air shopping centers, announced that it has acquired sponsor interest in a 10-property portfolio recently appraised at $644 million and totaling 3.5…
prnewswire.com Pine Tree Acquires Sponsor Interest in a 10-Property, $644M Shopping Center Portfolio CHICAGO, Oct. 20, 2026 /PRNewswire/ -- Pine Tree, a national owner and operator of open-air shopping centers, announced that it has acquired sponsor interest in a 10-property portfolio recently…
benzinga.com Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket Alcoa shares rose after Q3 earnings beat estimates; Rubico and others surged, while Nuburu, Jaguar Health and other stocks fell premarket.
benzinga.com SITE Centers (SITC) Stock Jumps 19% After Hours: What’s Driving the Surge? SITE Centers shares jump 18.94% premarket after announcing a $3 special cash distribution and plans to delist from the NYSE.
benzinga.com SITE Centers Reveals Plan to De-list From NYSE; Co. Expects De-listing Before December 4, 2026 SITE Centers Corp. (NYSE:SITC) today announced its intention to provide notice to the New York Stock Exchange of its plan to voluntarily de-list its common shares. The announcement was made in…
benzinga.com SITE Centers Announces The Sale Of Its Interests In The Dividend Trust Portfolio Joint Venture For Net Proceeds Of ~$32.4M SITE Centers Corp. (NYSE:SITC) today announced the sale of its interests in the Dividend Trust Portfolio joint venture for net proceeds of approximately $32.4 million.The Company’s Board of Directors…
businesswire.com SITE Centers Announces Sale of DTP Interests and Special Common Distribution BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Announces Sale of DTP Interests and Special Common Distribution.- benzinga.com SITE Centers Sells Shoppes At Paradise Pointe For $8.4M; Net Proceeds Reach ~$8M SITE Centers Corp. (NYSE:SITC) announced today the sale of Shoppes at Paradise Pointe (Fort Walton Beach, FL) for approximately $8.4 million. Net proceeds after adjustments for certain prorations,…
benzinga.com Top 3 Real Estate Stocks That May Rocket Higher This Quarter Opportunity to buy undervalued real estate stocks with low RSI values. Latest list of oversold players: CHCT (RSI 29.8), TRC (RSI 28.5), SITC (RSI 25)
benzinga.com Piper Sandler Maintains Neutral on SITE Centers, Lowers Price Target to $3.5 Piper Sandler analyst Alexander Goldfarb maintains SITE Centers (NYSE:SITC) with a Neutral and lowers the price target from $5 to $3.5.
benzinga.com SITE Centers Q2 FFO $(0.09) Misses $(0.04) Estimate, Sales $6.952M Miss $10.300M Estimate SITE Centers (NYSE:SITC) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 125 percent. This is a 156.25 percent decrease over earnings of $0.16…
benzinga.com Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket Atkore Inc (ATKR) shares rise on strong Q3 results and acquisition by Prysmian for $95.00 per share. Other gainers include UPC, YYAI, RITR, FCUV, SGLY, FNGR, ALAR, FERG, and BMY while FMFC, PWCM,…
benzinga.com SITE Centers Sells Meadowmont Market For ~$11M SITE Centers Corp. (NYSE:SITC) announced today the sale of Meadowmont Market (Chapel Hill, NC) for approximately $11.0 million. Net proceeds after adjustments for certain prorations, allocations and…- benzinga.com Piper Sandler Maintains Neutral on SITE Centers, Lowers Price Target to $5 Piper Sandler analyst Alexander Goldfarb maintains SITE Centers (NYSE:SITC) with a Neutral and lowers the price target from $6 to $5.
benzinga.com Reported Earlier, Show moreSITE Centers Sells The Pike Outlets In Long Beach For $50.0M, Declares Special Cash Distribution Of $1.00 Per Share The Company’s Board of Directors also declared a special cash distribution on its common shares of $1.00 per common share payable on July 31, 2026 to shareholders of record at the close of business…- benzinga.com SITE Centers Q1 FFO $(0.04) Misses $(0.01) Estimate, Sales $9.371M Miss $10.200M Estimate SITE Centers (NYSE:SITC) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.01) by 300 percent. This is a 125 percent decrease over earnings of $0.16…
- benzinga.com Piper Sandler Maintains Neutral on SITE Centers, Raises Price Target to $6 Piper Sandler analyst Alexander Goldfarb maintains SITE Centers (NYSE:SITC) with a Neutral and raises the price target from $5.5 to $6.
- benzinga.com Piper Sandler Maintains Neutral on SITE Centers, Lowers Price Target to $5.5 Piper Sandler analyst Alexander Goldfarb maintains SITE Centers (NYSE:SITC) with a Neutral and lowers the price target from $6.5 to $5.5.
benzinga.com Top 3 Real Estate Stocks That Could Blast Off In March Opportunity to buy undervalued real estate stocks with RSI near or below 30. Oversold companies include AHR, SITC, and O with recent stock decreases and low RSI values.- benzinga.com SITE Centers Sells Chicago Property 3030 North Broadway For $50.1M SITE Centers Corp. (NYSE:SITC) announced today the sale of 3030 North Broadway (Chicago, IL) for approximately $50.1 million, prior to closing costs, prorations and other closing adjustments.
benzinga.com SITE Centers Earnings Report: Q4 Overview 
benzinga.com Earnings Scheduled For February 26, 2026 
benzinga.com Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - benzinga.com SPX Technologies, Dycom Industries, BorgWarner, Hecla Mining, Ready Capital, SITE Centers, Thryv Holdings, Helen of Troy, AdvanSix, Sturm Ruger & Co, MGP Ingredients, Ceva, Shoe Carnival Removed from SmallCap 600 https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_december2025rebalance.pdf
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session 
benzinga.com Earnings Scheduled For August 5, 2025 - benzinga.com Earnings Scheduled For May 7, 2025
benzinga.com Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session